Cynata Director’s Share Options Expire
Company Announcements

Cynata Director’s Share Options Expire

Cynata Therapeutics Limited (AU:CYP) has released an update.

Cynata Therapeutics Limited has reported a change in the interests of Director Dr. Kilian Kelly, specifically relating to the expiry of 1,000,000 unlisted options. Post this change, Dr. Kelly retains 477,373 ordinary shares and still holds a significant number of unlisted and listed options, some exercisable until 2028. No new interests were acquired, and there were no changes in director’s interests in contracts.

For further insights into AU:CYP stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskCynata Therapeutics Unveils New Investor Presentation
TipRanks Australian Auto-Generated NewsdeskCynata Therapeutics Announces New Share Quotation
TipRanks Australian Auto-Generated NewsdeskCynata Therapeutics Advances in Clinical Trials and Research
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App